Krüger G, Keck J, Noll K, Pieper H
Arzneimittelforschung. 1984;34(11A):1612-24.
Starting from clenbuterol as a lead structure, new 4-amino-phenyl-aminoethanol analogues have been synthesized by different approaches. In these compounds one or both of the chlorine atoms of clenbuterol are replaced by other residues. This has led to compounds with high intrinsic beta 2-mimetic and/or beta 1-blocking activities. 1-(4-Amino-3-chloro-5-trifluoromethyl-phenyl)-2-tert.-butylamino-ethanol hydrochloride (mabuterol) has been selected for clinical development. A detailed description is given also of the syntheses of intermediary new acetophenone derivatives as well as of the resolution of mabuterol into its enantiomers.
以克仑特罗作为先导结构,通过不同方法合成了新型4-氨基-苯基-氨基乙醇类似物。在这些化合物中,克仑特罗的一个或两个氯原子被其他基团取代。这产生了具有高内在β2-拟交感神经活性和/或β1-阻断活性的化合物。1-(4-氨基-3-氯-5-三氟甲基-苯基)-2-叔丁基氨基-乙醇盐酸盐(马布特罗)已被选用于临床开发。文中还详细描述了新型苯乙酮衍生物中间体的合成以及马布特罗拆分为对映体的过程。